# Inmune Bio, Inc.: Form DEF 14A, filed Oct 14, 2025

- Company: [Inmune Bio, Inc.](/companies/inmb.md) (CIK 1711754)
- Form: DEF 14A
- Filed: 2025-10-14
- Accepted by EDGAR: Oct 14, 2025, 16:03 ET
- Period: 2025-11-18
- Accession: 0001213900-25-098715
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025098715/ea0259630-02.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1711754/000121390025098715/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1711754/000121390025098715/ea0259630-02.htm

Filed Oct 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-098715. Last ingested by Listed: Nov 5, 2026, 16:25 ET. No prices; not investment advice.
